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Healthcare-associated infections due to cefotaxime-resistant (CTX-R)
Enterobacteriaceae have become a major public health threat, especially in intensive
care units (ICUs). Often acquired nosocomially, CTX-R Enterobacteriaceae can
be introduced initially by patients at admission. This study aimed to determine
the prevalence and genetic characteristics of CTX-R Enterobacteriaceae-intestinal
carriage in ICU patients, to evaluate the rate of acquisition of these organisms during
hospitalization, and to explore some of the associated risk factors for both carriage and
acquisition. Between December 2014 and February 2015, the 63 patients admitted in
the ICU of Charles Nicolle hospital were screened for rectal CTX-R Enterobacteriaceae
colonization at admission and once weekly thereafter to identify acquisition. CTX-R
Enterobacteriaceae fecal carriage rate was 20.63% (13/63) at admission. Among the
50 non-carriers, 35 were resampled during their hospitalization and the acquisition
rate was 42.85% (15/35). Overall, 35 CTX-R Enterobacteriaceae isolates were
collected from 28 patients (25 Klebsiella pneumoniae, seven Escherichia coli, and three
Enterobacter cloacae strains). Seven patients were simultaneously colonized with two
CTX-R Enterobacteriaceae isolates. CTX-M-15 was detected in most of the CTX-R
Enterobacteriaceae isolates (30/35, 88.23%). Three strains co-produced CMY-4 and
22 strains were carbapenem-resistant and co-produced a carbapenemase [OXA-48
(n = 13) or NDM-1 (n = 6)]. Molecular typing of K. pneumoniae strains, revealed eight
Pulsed field gel electrophoresis (PFGE) patterns and four sequence types (ST) [ST101,
ST147, ST429, and ST336]. However, E. coli isolates were genetically unrelated and
belonged to A (n = 2), B1 (n = 2) and B2 (n = 3) phylogenetic groups and to ST131 (two
strains), ST572 (two strains), ST615 (one strain) and ST617 (one strain). Five colonized
patients were infected by CTX-R Enterobacteriaceae (four with the same strain identified
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from their rectal swab and one with a different strain). Whether imported or acquired
during the stay in the ICU, colonization by CTX-R Enterobacteriaceae is a major risk
factor for the occurrence of serious nosocomial infections. Their systematic screening in
fecal carriage is mandatory to prevent the spread of these multidrug resistant bacteria.
Keywords: cefotaxime resistance, gut colonization, ICU
INTRODUCTION
Gastrointestinal colonization with multidrug resistant bacteria
(MDR; resistant to three or more classes of antibiotics),
including cefotaxime-resistant (CTX-R) Enterobacteriaceae,
may be associated with subsequent clinical infection and
this constitutes a reservoir for transmission that may remain
unidentified in hospitals which do not implement active
surveillance testing. Many factors are associated with CTX-R
Enterobacteriaceae fecal carriage including antibiotic exposure,
malignancy, non-surgical invasive procedures, prolonged
hospital stay, admission to intensive care units (ICU), and
sharing a room with known carriers (Thiébaut et al., 2012).
A recent study emphasized on the importance of identifying
individuals carrying antimicrobial resistant bacteria in both
patient and healthy populations (Ben Sallem et al., 2014). An
increase in the proportion of carriers in the community increases
the risk that other individuals will also become carriers via
human-to-human transmission. In addition, the admission
into hospital of carriers of MDR bacteria increases the risk of
other hospitalized patient to acquire the fecal carriage or also
contract an infection with these MDR bacteria (Razazi et al.,
2012).
In Tunisia, investigations of fecal carriage of MDR bacteria
are rare (Ben Sallem et al., 2012; Tarchouna et al., 2014;
Sana et al., in press). The present prospective study aimed
to determine the prevalence of CTX-R Enterobacteriaceae-
intestinal carriage in patients newly admitted at the ICU of
Charles Nicolle hospital, to evaluate the rate of acquisition of
these organisms during their ensuing hospitalization, and to
explore some of the associated risk factors for both carriage and
acquisition.
PATIENTS AND METHODS
Design of the Study
A prospective study including all patients with fecal colonization
or infection due to CTX-R Enterobacteriaceae was conducted
in the ICU of the Charles Nicolle Hospital of Tunis (Tunisia)
from December 2014 to February 2015. The unit had 12 beds
located in private rooms. For each patient, the demographic
characteristics, medical history, and reason for hospitalization
were recorded. A single rectal swab specimen was collected from
each patient at admission. For original non-carriers, follow-
up cultures were performed at weekly intervals until hospital
discharge or positive detection. Imported carriers were defined
as patients found to be colonized with CTX-R Enterobacteriaceae
at admission. The acquisition rate was defined as the number
of patients who were not colonized at admission but become
colonized afterwards, divided by the number of patients not
colonized at admission. Medical record review was done by one
of the investigators, after clearance of the ward departmental
heads.
Sample Processing and Microbial Study
Each rectal swab was inoculated onto desoxycolate lactatose agar
(Biokar diagnostics) supplemented with cefotaxime (2 mg/L).
Each enterobacteria colonies which were judged to differ in
morphology (size, shape, consistency, and color) were selected
from each sample and identified using the API 20E system
(Biomerieux).
Antimicrobial susceptibility testing to 18 antibiotics
(amoxicillin, amoxicillin-clavulanic acid, ceftazidime,
cefotaxime, aztreonam, cefoxitin, imipenem, ertapenem,
gentamicin, amikacin, tobramycin, nalidixic acid, ciprofloxacin,
trimethoprim-sulfamethoxazole, tetracyclin, minocyclin,
fosfomycin, and chloramphenicol) was determined by the agar
disk diffusion method on Mueller-Hinton (MH) agar plates
(Bio-Rad) according to the CA-SFM guidelines (http://www.
sfm-microbiologie.org/).
Isolates were screened for extended-spectrum beta-lactamases
(ESBL)-phenotype by double-disk synergy test (DDST) with
cefotaxime, ceftazidime, and amoxicillin-clavulanic acid disks.
CTX-R Enterobacteriaceae isolates showing a negative-ESBL-
phenotype with resistance to amoxicillin-clavulanic acid and to
cefoxitin were classified as AmpC producers. For isolates showing
decreased susceptibility to carbapenems, a modified Hodge test
(MHT) was conducted as previously described (Poirel et al.,
2011a).
Risk Factor Analysis
To investigate the risk factors associated with fecal carriage
within groups (imported and acquired carriers), carriers were
compared with non-carriers in terms of exposure to the different
variables studied. Carrier patients were defined as those with
one rectal swab test-positive result for CTX-R Enterobacteriaceae.
Carriage detected more than 72 h after ICU admission was
considered ICU-acquired CTX-R Enterobacteriaceae. The period
between admission and acquisition of CTX-R Enterobacteriaceae
carriage was defined as the surveillance period. Demographic
data, characteristics at admission (patient’s location prior to
admission, co-morbidities), antibiotic exposure during ICU
stay, and outcome were collected for CTX-R Enterobacteriaceae
carriers and non-carriers. Univariate analysis of discrete variables
was performed using the two-sided Pearson’s chi-squared and
Fisher’s exact tests (a P < 0.05 was considered statistically
significant).
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Detection and Characterization of
β-Lactamase Genes
Detection and characterization of bla genes were performed by
PCRs and sequencing. Isolates showing positive DDST were
screened for blaCTX−M, blaSHV, blaTEM, and blaGES (Saladin et al.,
2002), while those with AmpC-phenotype were screened for
plasmid-mediated AmpC-β-lactamases genes (blaMOX, blaCIT,
blaDHA, blaACC, blaEBC, and blaFOX; Pérez-Pérez and Hanson,
2002). Isolates with reduced susceptibility to carbapenems and
positive MHT were screened for blaOXA-48, blaKPC, blaNDM, and
blaGES genes (Poirel et al., 2011a).
Detection of Associated Plasmid-Mediated
Quinolone Resistance (PMQR) Genes
The presence of plasmid-mediated genes associated with
quinolones resistance (qnrA, qnrB, and qnrS) was determined by
multiplex PCR and sequencing (Cattoir et al., 2007).
Genetic Environments
The genetic environments of blaCTX-M-15, blaOXA-48, and
blaNDM-1 genes were determined by PCR mapping using specific
primers as described previously (Eckert et al., 2006; Poirel et al.,
2011b, 2012).
Transfer of Resistance Determinants
Genetic support was studied by matting-out assays for all strains.
Clinical strains were used as donors. For rifampin-susceptible
isolates, a rifampin-, and nalidixic acid-resistant E. coliK12 strain
was used as recipient, while for rifampin-resistant and sodium
azide-susceptible isolates, a sodium azide resistant E. coli C600
was used as recipient. Transconjugants were selected on MH
agar plates containing sodium azide (100 mg/L) or rifampicin
(250 mg/L) and cefotaxime (2 mg/L). Transconjugants resistance
profiles were tested by disk diffusion method and PCR.
Molecular Typing of Isolates
E. coli isolates were assigned to the phylogenetic groups A, B1, B2,
or D using a PCR strategy with specific primers for chuA, yjaA,
and TspE4.C2 determinants as previously described (Clermont
et al., 2000).
The epidemiological relationship between the different
isolates was determined by pulsed-field gel electrophoresis
(PFGE) of XbaI-digested genomic DNA of all recovered isolates
as previously described (Sáenz et al., 2004). Patterns were
visually compared and analyzed according to previously reported
criteria (Tenover et al., 1995; Sáenz et al., 2004). Although,
when identical PFGE patterns of strains (K. pneumoniae and
E. coli) were observed, representative strains were selected for
multilocus sequence typing (MLST), performed as previously
described (Sáenz et al., 2004). All the amplicons were sequenced
and compared with the sequences deposited in the MLST
database (http://bigsdb.web.pasteur.fr/), to know the specific
allele combination and the sequence type (ST).
Virulence Factors
E. coli isolates were screened for the presence of 18 virulence
genes [fimH, afa/draBC, sfa/focDE, papG (allele I, II, and III),
cnf1, sat, hlyA, iutA, iroN, fyuA, iha, kpsM II, ompT, traT, and usp]
using multiplex PCRs. Isolates were defined as extra-intestinal
pathogenic E. coli (ExPEC) if positive for two of the following
genes or gene sets: papA and/or papC (P fimbriae), sfa/focDE
(S and F1C fimbriae), afa/draBC (Dr-binding adhesins), kpsM
II (group 2 capsule), and iutA (aerobactin siderophore system;
Johnson et al., 2003).
K. pneumoniae isolates were screened for the presence
of nine virulence genes (ycfM, mrkD, entB, ybtS, kfu, iroN,
magA, allS, and rmpA) using multiplex PCRs (Lafeuille et al.,
2013).
The virulence score was calculated as the sum of
all virulence factors (VF) for which the isolate tested
positive.
RESULTS
Study Population and Prevalence of CTX-R
Enterobacteriaceae Carriage
During the study period, 63 patients were admitted to the ICU
of the Charles Nicolle Hospital. The male-to-female ratio was
1.25; the median age was 54 years (range, 7–87 years; Table 1).
The median length of ICU stay was 6 days (2–136 days).
Most patients were admitted for medical reasons (69.8%, 44/63)
and transferred from different wards of our hospital (80.95%,
51/63). All patients received mechanical ventilation and had
venous and/or arterial devices. Twenty-eight patients (44.44%)
were screened only once, while 35 (55.55%) patients had at
least two swabs (range, 2–5 swabs). CTX-R Enterobacteriaceae
prevalence at admission was 20.63% (13/63). Of the 50 non-
carriers, follow-up rectal swabs were realized for only 35 patients,
resulting in a CTX-R Enterobacteriaceae acquisition rate of
42.85% (15/35). The 15 remaining patients were excluded (9
were discharged or transferred and six died before the scheduled
follow-up sampling; Figure 1). Twenty-one patients harbored a
single CTX-R Enterobacteriaceae species and seven harbored two
different CTX-R Enterobacteriaceae species. The median time
between admission in ICU and acquisition of carriage was 6 days
(range, 3–15 days).
Risk Factors for CTX-R
Enterobacteriaceae Carriage
In univariate analysis, significant risk factors for CTX-R
Enterobacteriaceae carriage on admission were prior antibiotic
use (P = 0.03) and infection at admission (P = 0.007; Table 1).
In addition, CTX-R Enterobacteriaceae fecal colonization
at admission was significantly associated with patients’
outcomes (P = 0.05). However, risk factors such as age,
gender, location prior ICU admission, comorbidities such
as diabetes and hypertension, previous hospitalization, and
duration did not show any significant correlation with carriage
of CTX-R Enterobacteriaceae (P > 0.05). No significant risk
factor for CTX-R Enterobacteriaceae hospital acquisition
in univariate analysis was observed (Table 1). All patients
(carriers and non-carriers) underwent invasive procedures
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TABLE 1 | Characteristics of patients with cefotaxime-resistant Enterobacteriaceae in fecal carriage at ICU admission and during ICU hospitalization.
Variables Imported CTX-R
Enterobacteriaceae
carriers (n = 13)
Non-imported CTX-R
Enterobacteriaceae
carriers (n = 50)
ICU-acquired CTX-R
Enterobacteriaceae
carriers (n = 15)
Non-ICU-acquired CTX-R
Enterobacteriaceae
carriers (n = 20)
Age, median (range) 60 (11–78) 54 (7–79) 53 (29–87) 47 (7–79)
≤15 years 1 3 0 2
16<<59 years 5 29 9 13
≥60 years 7 18 7 4
Gender (Male) n (%) 7 (53.84) 12 (63) 10 (66.6) 12 (60)
Reason of ICU admission n (%)
Medical reason for ICU admission 7 (53.84) 37 (74) 12 (80) 13 (65)
Surgery before ICU admission 6 (46.15) 13 (26) 4 (26.6) 6 (30)
Polytraumatism 2 (15.38) 8 (16) – –
Antibiotic use before ICU admission n (%) 7 (53.84) 12 (24) 3 (20) 6 (30)
3rd cephalosporin generation 2 8 8 (53.3) 6 (30)
Carbapenem 1 2 5 (33.3) 8 (40)
Amoxicillin-clavulanic acid 5 4 8 (53.3) 10 (50)
Fluoroquinolone 0 3 10 (66.6) 7 (35)
Aminoside 3 3 6 (40) 2 (10)
Glycopeptide – – 3 (20) 6 (30) *
Hospital days before ICU admission, median (range) 5 (2–28) 3 (1–17)* – –
≤72 h 3 28 – –
>72 h 10 22 – –
COMORBIDITIES, n
Diabetes 3 13 4 5
HTA 3 10 2 6
Infection at ICU admission, n (%) 5 (38.46) 3 (6) * 2 (12.5) 0 (0)
Infection with CTX-R Enterobacteriaceae during ICU
hospitalization, n (%)
– – 4 (25) 2 (10.52)
ORIGIN
Charles Nicolle hospital wards 9 42 13 17
Emergency unit 2 15 5 6
Cardiology 0 4 1 3
Surgical units 2 2 2 2
Gynecology 0 5 1 1
Neurology 0 2 0 2
Orthopedic 1 4 2 2
Urology 1 4 1 0
Gastrology 1 0 – –
Medicine 1 1 – –
Maxillo-facial 0 1 – –
ORL 0 1 1 0
Pediatric 1 2 0 1
Pneumology 0 1 – –
Private hospital 4 8 3 2
OUTCOMES, n (%)
Death 2 (15.38) 22 (44) * 8 (53) 8 (40)
Discharge or transferred 11 (84.61) 28 (56) 7 (46.6) 12 (60)
Hospital days before ICU admission, median (range) – – 3.5 (2–14) 5 (1–15)
≤72 h, n – – 8 9
>72 h, n – – 8 10
ICU days before acquisition, median (range) – – 5 (3–15) 10 (4–25)
≤72 h, n – – 2 0
>72 h, n – – 14 19
*0.05 ≤ P ≤ 0.007; –, not applicable; CTX-R Enterobacteriaceae, cefotaxime-resistant Enterobacteriaceae.
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FIGURE 1 | Flow chart of the patients.
including intravenous or urinary catheterization during
hospitalization.
Bacterial Species Identification and
Distribution of Resistance Genotypes of
CTX-R Enterobacteriaceae Isolates
In all, 35 CTX-R Enterobacteriaceae strains were isolated
from 28 patients. Ten K. pneumoniae, six E. coli, and two
Enterobacter cloacae isolates were identified at admission,
while 15 K. pneumoniae, one E. coli, and one E. cloacae
isolates were acquired later. The acquisition rates of fecal
carriage of cefotaxime-resistant K. pneumoniae, E. coli and E.
cloacae were 42.85% (15/35), 2.85% (1/35), and 2.85% (1/35),
respectively. All isolates, except one (AmpC-phenotype), were
ESBL producers (n = 34). Among the ESBL producers, three
showed the combination of the both phenotypes, ESBL and
AmpC. Associated resistances were as follows: cefoxitin (n= 24),
ertapenem (n = 22), imipenem (n = 19), gentamicin (n = 27),
tobramycin (n = 29), amikacin (n = 11), nalidixic acid (n = 32),
ciprofloxacin (n = 31), tetracyclin (n = 29), chloramphenicol (n
= 34), and trimethoprim-sulfamethoxazole (n = 29; Table 2).
Among the carbapenem-resistant strains, 16 showed a positive
MHT.
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TABLE 2 | XbaI-PFGE profile and characteristics of cefotaxime-resistant Enterobacteriaceae strains collected in intestinal flora of ICU-patients.
Ecl, Enterobacter cloacae; Kp, Klebsiella pneumonia; Ec, E. coli; ND, not determined; ESBL, extended-spectrum-beta-lactamase; PFGE, pulsed-field gel electrophoresis; MLST, multi
locus sequence typing; ST, sequence type.
aPatient infected by the same strain recovered in his rectal swab.
bPatient infected and colonized by two different strains.
cMLST was performed only for selected strains.
dVirulence score was calculated as the sum of all virulence genes for which the isolates tested positive.
ePlasmidic AmpC producing-strain (CMY-2 type) but none ESBL producer.
fE. coli belonged to phylogroups B2.
gE. coli belonged to phylogroups B1.
hE. coli belonged to phylogroups A.
β-Lactamase Genes Detection and PMQR
Genes
ESBL genes were identified as blaCTX-M-15 (n= 30), blaCTX-M-14
(n = 3), and blaCTX−M−27 (n = 1). The strain with the AmpC-
phenotype (Ec2) harbored blaCMY-2. Among the blaCTX-M-15-
producers, three co-produced blaCMY-4, six blaNDM-1, and
10 blaOXA-48. All blaCTX-M-14-producers harbored blaOXA-48.
In addition, blaTEM-1, blaSHV-1, and blaOXA-1 genes were
concomitantly present in 29, 26, and 14 isolates, respectively
(Table 2). qnrB1, qnrS1, and qnrA6 were detected in 13, 3, and
2 strains, respectively.
Transfer of Resistance
Fifteen over thirty (50%) CTX-M-15 ESBL were successfully
transferable by conjugation. However, transfer of CTX-M-14,
CTX-M-27, and CMY-2 enzymes were not successful, despite
three separate attempts. blaOXA-1, blaTEM-1, and blaNDM-1
genes were co-transferred in 13, 12, and 5 cases, respectively.
Depending on the strain, other resistances were co-transferred,
mostly gentamicin (12/13; 92.3%), tetracyclin (6/13; 46.15%) and
rarely trimethoprim-sulfamethoxazole (2/8; 25%; Table 3). In
addition, blaCMY-4 and blaOXA-48 genes were transferable alone
in three and seven strains, respectively and co-transferred in one
strain (TCKp5).
Molecular Typing of Isolates
Among the 25 non-duplicated K. pneumoniae strains (isolated
from 25 patients), 21 were clustered in four PFGE patterns
labeled P1a (11 strains), P3 (2 strains), P4 (6 strains), and P6 (2
strains). Singletons were labeled P1b, P5, P7, and P8 (Table 2).
These PFGE patterns corresponded to ST101 for PFGE patterns
P1a and P1b, to ST147 for P3 and P7 patterns and to ST429 and
ST336, for P6 and P8 PFGE patterns, respectively (Table 2). In
contrast, PFGE analysis showed heterogeneous clones among E.
coli (labeled P10, 12, 13, 14, 15, 16, and 17) and E. cloacae (labeled
P18, 19, and 20) isolates (Table 2).
In addition, phylogenetic analysis revealed that E. coli isolates
belonged to the following groups: A (n = 2), B1 (n = 2), and B2
(n= 3); and the following sequence types associated phylogenetic
groups were detected: ST131-B2 (2 strains), ST572-B1 (2 strains),
ST615-A (one strain), and ST617-A (one strain).
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TABLE 3 | Characteristics of cefotaxime-resistant Enterobacteriaceae strains collected in intestinal flora of ICU-patients and their transconjugants.
Strain Resistance profile to non-beta-lactams ESBL genes Associated bla genes
Kp6 GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-1, blaOXA-48
TCKp6 GEN, TOB, NET, AMK blaCTX-M-15 blaTEM-1, blaOXA-1
Kp10 GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-1, blaOXA-48
TCKp10 (1) GEN, TOB, NET, AMK, TET blaCTX-M-15 blaTEM-1, blaOXA-1
TCKp10 (2) None None blaOXA-48
Kp15b GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, CHL, SXT blaCTX-M-14 blaSHV-1, blaTEM-1, blaOXA-48
Kp19b GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, CHL blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-48
Kp7 GEN, TOB, NET, MNO, TET, NAL, CIP, CHL, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaCMY-4
TCKp7 TET, CHL, SXT None blaCMY-4
Kp13 GEN, TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaNDM−1, blaSHV-1, blaTEM-1, blaOXA-1
TCKp13 GEN, TOB, NET blaCTX-M-15 blaNDM-1, blaTEM-1, blaOXA-1
Kp14b GEN, TOB, NET, MNO, TET, NAL, CHL, SXT blaCTX-M-15 blaNDM-1, blaSHV-1, blaTEM-1, blaOXA-1
Kp22 GEN, TOB, NET, MNO, TET, CIP, SXT blaCTX-M-15 blaNDM-1, blaSHV-1, blaTEM-1, blaOXA-1
TCKp22 GEN, TOB blaCTX-M-15 blaNDM-1, blaTEM-1, blaOXA-1
Kp2 GEN, TOB, NET, MNO, TET, NAL, CIP, FOS, SXT blaCTX-M-15 blaNDM-1, blaSHV-1, blaTEM-1, blaOXA-1
TCKp2 GEN, TOB blaCTX-M-15 blaNDM-1, blaTEM-1, blaOXA-1
Kp16b GEN, NET, MNO, NAL, CIP, SXT blaCTX-M-15 blaSHV-1, blaTEM-1
Kp9 GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, FOS, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-1, blaOXA-48
TCKp9 (1) TET, TOB, NET, AMK, FOS blaCTX-M-15 blaTEM-1, blaOXA-1
TCKp9 (2) FOS None blaOXA-48
Kp12 GEN, TOB, NET, MNO, TET, CIP, CHL, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-48
TCKp12 None None blaOXA-48
Kp20 GEN, AMK, TOB, NET, NAL, CIP, FOS blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-1, blaOXA-48
TCKp20 (1) TET, GEN, TOB, NET blaCTX-M-15 blaTEM-1, blaOXA-1
TCKp20 (2) None None blaOXA-48
Kp21 GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, CHL blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-1, blaOXA-48
TCKp21 (1) GEN, TOB, NET, AMK, FOS blaCTX-M-15 blaTEM-1, blaOXA-1
TCKp21 (2) FOS None blaOXA-48
Kp25 GEN, TOB, AMK, NET, CIP, NAL, TET blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-1, blaOXA-48
TCKp25 TET, GEN, TOB, AMK, FOS blaCTX-M-15 blaTEM-1, blaOXA-1
Kp23b GEN, AMK, TOB, NET, MNO, TET, NAL, CIP, FOS, CHL, SXT blaCTX-M-14 blaSHV-1, blaTEM-1, blaOXA-48
Kp17 GEN, AMK, TOB, NET, TET, NAL, CIP, FOS, CHL, SXT blaCTX-M-14 blaSHV-1, blaTEM-1, blaOXA-48
TCKp17 None None blaOXA-48
Kp18b GEN, TOB, NET, TET, NAL, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaOXA-48
Kp5 GEN, TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaSHV−1, blaTEM-1, blaCMY-4, blaOXA48
TCKp5 TET None blaOXA−48,blaCMY-4
Kp1 GEN, TOB, NET, MNO, TET, NAL, CIP, FOS, SXT blaCTX-M-15 blaNDM-1, blaSHV-1, blaTEM-1, blaOXA-1
TCKp1 GEN, TOB blaCTX-M-15 blaNDM-1, blaTEM-1, blaOXA-1
Kp11 GEN, TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaNDM-1, blaSHV-1, blaTEM-1, blaOXA-1
TCKp11 GEN, TOB blaCTX-M-15 blaNDM-1, blaTEM-1, blaOXA-1
Kp4 AMK, TOB, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaSHV-1, blaTEM-1, blaCMY-4
TCKp4 TET, SXT None blaCMY-4
Kp3b GEN, TOB, NET, NAL, CIP, SXT blaCTX-M-15 blaSHV-1, blaTEM-1
Kp24b TOB, NET, TET, NAL, CIP, SXT blaCTX-M-15 blaTEM-1
Kp8b TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaSHV-1, blaTEM-1
Ec7 None blaCTX-M-15 blaSHV-1
TCEc7 None blaCTX-M-15 None
Ec4b GEN, TOB, NET, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaSHV-1
Ec3 MNO, TET, CHL, SXT blaCTX-M-15 blaTEM-1
TCEc3 None blaCTX-M-15 None
Ec5 GEN, TOB, MNO, TET, NAL, CIP, SXT blaCTX-M-15 blaOXA-1
TCEc5 GEN, TOB, TET, SXT blaCTX-M-15 blaOXA-1
(Continued)
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TABLE 3 | Continued
Strain Resistance profile to non-beta-lactams ESBL genes Associated bla genes
Ec6b TET, NAL, CIP, NOR, SXT blaCTX−M−27 None
Ec1b NAL, CIP blaCTX-M-15 None
Ec2b MNO, TET, NAL, CIP, CHL, SXT blaCMY−2
a None
Ecl3b GEN, TOB, MNO, NAL, CIP, NOR, CHL, SXT blaCTX-M-15 blaTEM-1
Ecl2b GEN, TOB, NET, MNO, TET, NAL, CIP, CHL, SXT blaCTX-M-15 blaTEM-1, blaOXA-1
Ecl1 GEN, TOB, NET, MNO, TET, NAL, CIP, CHL, SXT blaCTX-M-15 blaTEM-1
TCEcl1 TET, GEN, TOB, CHL, SXT blaCTX-M-15 blaTEM-1, blaOXA-1
Ecl, Enterobacter cloacae; Kp, Klebsiella pneumoniae; Ec, E. coli; NAL, nalidixic acid; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole; TET, tetracyclin; MNO, minocyclin;
GEN, gentamicin; TOB, tobramycin; AMK, amikacin; NET, netilmicin, CHL, chloramphenicol; FOS, fosfomycin; ND, not determined; ESBL, extended-spectrum-beta-lactamase; TC,
Transconjugant.
aplasmidic AmpC producing-strain (CMY-2 type) but none ESBL producer.
bresistance transfer was not obtained.
Virulence Genotyping of
Cefotaxime-Resistant E. coli and
K. pneumoniae
Of the 18 VFs sought, fimH virulence gene was detected in all
cefotaxime-resistant E. coli isolates (except in Ec5), papGII in 4,
iutA in 4, malX in 4, iroN in 1 isolate. VF scores were in the
range of 3–12 (median, 6). E. coli isolate Ec4, typed as ST131-
B2, contained 12 VFs (fimH, malX, fyuA, iutA, KpsM II, hlyA,
papGII, traT, cnf, usp, iha, and sat). Nevertheless, papGI, papGIII,
or afa/draBC virulence genes were not detected in any isolate
(Table 2).
ThemrkD gene was detected in allK. pneumoniae isolates. The
entB, ybtS, kfu, and rmpA genes were detected in 24, 18, 12, and
10 isolates, respectively (Table 2). VF scores were in the range of
1–5 (median, 3).
Genetic Environment of blaCTX-M-15,
blaNDM-1, and blaOXA-48
ISEcp1were identified upstream of blaCTX-M-15 in 26 strains. The
organization ISAba125-blaNDM-1-bleMBL and LysR-blaOXA−48-
Tnp1999 were identified as genetic structures surrounding
blaNDM-1 in all strains and blaOXA-48 in 11 strains, respectively.
Nosocomial Infections
During the study, seven cases of ICU-acquired infections by
CTX-R Enterobacteriaceae occurred among the 63 hospitalized
patients. The cause of infection was septicemia (n = 3),
pulmonary infection (n = 2), catheter related infection (n = 1)
and intra-abdominal infection (n = 1). The incidence rate
of ICU-acquired CTX-R Enterobacteriaceae infections was
estimated at 11.1% during the study period. Five of the seven
infected patients were also CTX-R Enterobacteriaceae carriers;
four of themwere infected with their carriage strain (patientsM1,
M8, M16, and M24) and the remaining patient (patient M5) was
infected with a different strain. For this patient (M5), infection
preceded the CTX-R Enterobacteriaceae carriage. For the two
infected patients and non-carriers of CTX-R Enterobacteriaceae,
they were infected with strains P1 and P8 pulsotypes. Thus,
all acquired infections cases were caused by K. pneumoniae
strains which belonged to the same ST clones that colonized
ICU hospitalized patients in the same period (Table 4). All
TABLE 4 | Comparison of ST types bacteria: colonization vs. infection.
PFGE/MLST Colonization Infection
(imported/acquired)
P1/ST101 (n = 14) 11(4/7) 3
P3/ST147 (n = 4) 2(1/1) 1
P8/ST336 (n = 1) 1(0/1) 1
P4/ND (n = 6) 6(4/0) 2
PFGE, pulsed-field gel electrophoresis; MLST, multi locus sequence typing; ST, sequence
type; ND, not determined.
ICU-acquired infections were caused by CTX-M-15 producing
K. pneumoniae strains (n = 7). Five of them co-produced a
carbapenemase [OXA-48 (n = 3) and NDM-1 (n = 2)] and one
co-produced CMY-4 (Table 2).
The median length of ICU stay before the occurrence of ICU-
acquired infections caused by CTX-R Enterobacteriaceae was 12
days (range, 3–20 days). The median time elapsed between the
demonstration of the CTX-R Enterobacteriaceae-carriage and the
diagnosis of the ICU-acquired infection was 5.5 days (range, 3–12
days).
DISCUSSION
CTX-R Enterobacteriaceae are considered as a major cause
of morbidity and mortality worldwide. They are becoming
prevalent causal agents of nosocomial infections, especially
in ICUs (Bonten and Weinstein, 1996; Razazi et al., 2012).
Epidemiologic features of circulation of these organisms have
been described by several authors, who have identified risk factors
for microbiota colonization and infection and applied molecular
tracing as a tool for assessing transmission pathways, cross-
transmission burden and addressing drug-resistance control
strategies (Razazi et al., 2012; Thiébaut et al., 2012; Ko et al., 2013;
Kim et al., 2014).
The main finding from this 3-month study is the high rate
of fecal carriage of CTX-R Enterobacteriaceae at ICU admission
(20.63%), with K. pneumoniae representing the most common
CTX-R Enterobacteriaceae species recovered (76.92%) especially
for the acquired-carriage; which is in accordance with previous
Frontiers in Microbiology | www.frontiersin.org 8 November 2016 | Volume 7 | Article 1859
Maamar et al. Fecal Carriage of ESBL-Producing Isolates
studies (Thiébaut et al., 2012; Tarchouna et al., 2014). TheseMDR
bacteria were probably selected during hospitalization preceding
ICU transfer; however, a community origin cannot be eliminated.
Imported CTX-R Enterobacteriaceae carriers are transferred
from different wards of Charles Nicolle Hospital or from private
hospitals, which demonstrate dissemination in the entire hospital
and implying inter-institutional or even regional transmission
of these pathogens. In accordance with other reports (Razazi
et al., 2012; Thiébaut et al., 2012), we found that duration of
hospitalization before ICU admission was significantly associated
with imported fecal carriage (P = 0.05). In addition, a high
percentage of imported carriers had received antibiotics before
their ICU admission, which has certainly played an important
role in the selection of CTX-R Enterobacteriaceae. However,
no statistically significant relationship was found (P = 0.08).
A weakness of the present study was that we were unable
to collect data about patients in relation with their prior
hospitalization and antibiotic use in the 3 months preceded their
admission.
The admission screening is mandatory for its importance in
population assessment of the full reservoir of organisms and the
respect of proper practice guidelines like contact isolation and
sterile barrier precautions are advocated.
In our study, CTX-R Enterobacteriaceae acquisition rate was
alarming (42.85%), higher than that reported in France and
Korea (Razazi et al., 2012; Kim et al., 2014). The median time
of stay in our ICU for acquisition of CTX-R Enterobacteriaceae
(5 days) was slightly lower to those reported in China (7 days)
and France (9 days; Razazi et al., 2012; Ma et al., 2015). Almost
all patients (carriers and non-carriers) received antibiotics and all
of them underwent invasive procedures including intravenous or
urinary catheterization during hospitalization. Thus, no specific
risk factors to acquired CTX-R Enterobacteriaceae among gut
microbiota have been identified, in univariate analysis, except the
use of glycopeptides (P = 0.05).
However, in contrast with the very high frequency of
CTX-R Enterobacteriaceae colonization, infection occurred
only in 11.11% of patients, accordingly with other studies.
Asymptomatically colonized patients may act as a reservoir
for persistence of CTX-R Enterobacteriaceae in the hospital
setting and this may provide further rationale for routine
surveillance screening in high-risk populations. Notably,
four of the patients who had an ICU-acquired infection
caused by CTX-R Enterobacteriaceae were found to
have been previously colonized in an average of 5.75
days (2–10 days) before infection with the same strain.
Therefore, a major risk factor for nosocomial infection is prior
colonization, as previously reported (Bonten and Weinstein,
1996).
In Tunisia, the fecal carriage of ESBL-producing
Enterobacteriaceae (ESBL-E) was reported in three previous
studies: one investigated children hospitalized in a pediatric
unit, one concerning healthy adults and another about healthy
children (Ben Sallem et al., 2012; Tarchouna et al., 2014;
Sana et al., in press). All these findings raise the question
of asymptomatic carriage of this pathogen not only in the
hospital settings but also in the community, which enhances
the spread of resistance genes by transmission from human-
to-human, patients-to-others and medical staff-to-patients or
contamination of the environment in our country.
Multiple investigators reported that most colonizing ESBL-E
isolates were K. pneumoniae in high-risk patients and associated
with hospital-onset infections, whereas E. coli was frequently
isolated in healthy individuals and was the predominant cause
of community-onset infections (Ben Sallem et al., 2012; Ko et al.,
2013; Tarchouna et al., 2014).
Our finding showed the diversity of β-lactamase genes
including blaCTX-M-15, blaCTX-M-14, blaCTX−M−27, and
blaCMY-2. blaCTX-M-15, the most dominant gene detected
among our strain collection, is the most prevalent ESBL gene
in human clinical isolates worldwide (Bonnet, 2004; Chouchani
et al., 2011). It is worth-mentioning that CTX-M β-lactamase
genes are widely known to be carried on a plasmid linked to
mobile genetic elements that are utilized as vehicles for resistance
genes horizontal movement, in addition to carry on resistance
to other antibiotics like aminoglycosides and fluoroquinolones.
Multidrug resistance profiles involving non-β-lactamase
antibiotics in ESBL-producing isolates may also contribute to the
increase in colonization pressure. Fluoroquinolone resistance is
becoming a common feature rather than an exception in ESBL-
producing isolates (Rodriguez-Martínez et al., 2011). Recent
studies have demonstrated co-transfer of qnr determinants on
ESBL-producing plasmids conferring resistance to nalidixic acid
with reduced susceptibility to fluoroquinolones.
In conclusion, imported or acquired CTX-R
Enterobacteriaceae colonization was found with high prevalence.
The majority of colonizing CTX-R Enterobacteriaceae isolates
was MDR strains co-carrying diverse resistance determinants.
Molecular epidemiologic analysis showed the circulation of
clonally related strains (mainly K. pneumoniae) showing that
cross-transmission play a major role on their acquisition.
Whether imported or acquired during the stay in ICU,
intestinal colonization by CTX-R Enterobacteriaceae is a major
risk factor for the occurrence of serious nosocomial infections
with limitations in the therapeutic options available for their
treatment. Thus, their systematic screening in fecal carriage, with
strict adherence to patient hygiene and infection control practices
are mandatory to prevent the spread of these MDR bacteria.
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